Congratulations to Caroline Ménard who has won the Canadian College of Neuropsychopharmacology Young Investigator Award ( https://ccnp.ca/ )
The Young Investigator Award, sponsored by Pfizer Canada Inc., is designed to recognize outstanding contributions in the field of research in neuropsychopharmacology by an individual young basic scientist or clinical investigator in Canada.
Dr. Menard’s research program aims at deciphering the neurobiology of mood disorders and stress resilience. Her lab combines behavioral experiments to functional, molecular, pharmacological and imaging studies and validate rodent findings in human samples to provide translational value to her basic projects.
Despite being an independent faculty for only 2 years, she already secured over 3 million $CAN including a Sentinel North Research Chair sponsored by Canada First Research Excellence Fund and funding from CIHR, NSERC, New Frontiers in Research Fund, FRQS and private foundations. Her team published several manuscripts in leading journals such as PNAS, Neuron, Nature Biomedical Engineering and the European Journal of Neuroscience. She has a broad background in neuroscience and psychiatric disorders with specific training and expertise in behavioral studies, vascular biology, immunology, pharmacology and brain plasticity. Her research includes 44 peer-reviewed publications (4 as corresponding author, 17 as first author, >2,000 citations, h-index: 22).
Over the last decade she has been very active in the fields of mental health, psychiatry and neuropsychopharmacology, evidenced by a number of honors including a prestigious Young Investigator Award from the Brain & Behavior Research Foundation (USA) and a selection in the Quebec Science magazine Top 10 discoveries of the year. She is also part of the highly competitive American College of Neuropsychopharmacology (ACNP) travel award program which annually select distinguished young scientists in the field of neuropsychopharmacology.
Read more in the CCNP’s newsletter :https://ccnp.ca/Content/PDF/CCNP_Mar_20_Newsletter.pdf